Reply to Comment by Arber C, Et Al. On: Real-World Expenditures and Survival Time After CAR-T Treatment for Large B-Cell Lymphoma in Switzerland. Swiss Med Wkly 2024, 154 (10), 3958. https://doi.org/10.57187/s.3958.